FDA Cannot Regulate Stem Cell Treatments, DC Circ. Hears – Law360 (subscription)
|
FDA Cannot Regulate Stem Cell Treatments, DC Circ. Hears
Law360 (subscription) Law360, Washington (October 21, 2013, 5:28 PM ET) — Regenerative Sciences LLC on Monday blasted the U.S. Food and Drug Administration’s attempt to regulate its stem cell treatments as a drug, telling a D.C. Circuit panel that the agency doesn’t have … |
